News

Dr. Yu Sato (graduate student) and Dr. Naohiro Kodama (professor) had their paper published in Journal for ImmunoTherapy of Cancer.
Please refer to the following page for details.

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Sato Y, Kodama T, Maesaka K, Kai M, Murai K, Tahata Y, Saito Y, Nakabori T, Ohkawa K, Tanaka S, Sakamori R, Miyazaki M, Furuta K, Ishida H, Matsumoto K, Tawara S Yakushijin T, Nozaki Y, Hosui A, Nishio A, Tatsumi N, Kakita N, Yoo C, Fukai M, Taketomi A, Hikita H, Tatsumi T, Takehara T.
Journal for ImmunoTherapy of Cancer. 2026;14:e013384.